There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 427-49-6 | MDL No. : | MFCD00019296 |
Formula : | C13H16O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WFLUEQCOAQCQLP-UHFFFAOYSA-N |
M.W : | 220.26 | Pubchem ID : | 98283 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.46 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 60.95 |
TPSA : | 57.53 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.88 cm/s |
Log Po/w (iLOGP) : | 1.8 |
Log Po/w (XLOGP3) : | 2.48 |
Log Po/w (WLOGP) : | 2.04 |
Log Po/w (MLOGP) : | 1.86 |
Log Po/w (SILICOS-IT) : | 2.04 |
Consensus Log Po/w : | 2.04 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.85 |
Solubility : | 0.313 mg/ml ; 0.00142 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.33 |
Solubility : | 0.102 mg/ml ; 0.000465 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.41 |
Solubility : | 0.859 mg/ml ; 0.0039 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.29 |
Signal Word: | Danger | Class: | N/A |
Precautionary Statements: | P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P310-P332+P313-P362-P403+P233-P405-P501 | UN#: | N/A |
Hazard Statements: | H315-H318-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 2 h; | To a mixture of racemic cyclopentylmandelic acid R/S(+/-)1 (4.47 g, 20 mmol) and potassium carbonate (7.01 g, 50 mmol) in DMF (50 ml), methyl iodide (8.64 g, 60 mmol) was added at room temperature. The mixture was stirred at room temperature for 2 h, and then poured into water and extracted with hexanes three times. Evaporation of the dried hexanes extract gave a crude product. Flash chromatography of the crude product on silica gel with 1.5:1 hexanes:methylene chloride gave the pure product 2 (3.02 g, 64percent). 1H NMR(CDCl3, 300 MHz): 1.32-1.37, 1.43-1.69 [8H, m, (CH2)4], 2.90 [1H, p, CHC(OH)], 3.74(1H, s, OH), 3.77 (3H, s, CH3), 7.25-7.37, 7.63-7.65 (5H, m, Ph) ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydroxide; In ethyl acetate; | Step 2. Synthesis of N-(piperidin-4-yl)-2-cyclopentyl-2-hydroxy-2-phenylacetamide The hydrochloride of the title compound was prepared in the same manner as described in Steps 2 to 3 of Example 1 using <strong>[427-49-6]2-cyclopentyl-2-hydroxy-2-phenylacetic acid</strong>. The hydrochloride was dissolved in a mixture of ethyl acetate and a 1N aqueous solution of sodium hydroxide. After the organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure to obtain the title compound. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With 4-methyl-morpholine; benzotriazol-1-ol; In DMF (N,N-dimethyl-formamide); at 0 - 20℃; for 20h; | The compound <strong>[427-49-6]2-cyclopentyl-2-hydroxy-2-phenylacetic acid</strong> (0.52 g, 2.36 mM) and (3S)- 1-BENZYL-3-AMINOPYRROLIDINE (0.5 g, 2.84 mM) were dissolved in dimethylformamide (10.0 ml) and N-methylmorpholine (1.3 ml, 11.8 mM) was added into it followed by the addition of 1-HYDROXYBENZOTRIAZOLE (0.32 g, 2.36 mM) at 0-5C. The reaction mixture was maintained at 0-5C for 1 hour and then at room temperature for 19 hours. The reaction mixture was poured into water (100.0 ml) with constant stirring. The organic compound was extracted with ethyl acetate. The ethyl acetate layer was washed with saturated sodium bicarbonate water and brine solution followed its drying and concentration over anhydrous sodium sulphate. The residue was purified by silica gel column chromatography using 10% methanol in chloroform to get the title compound. Yield = 95% (0. 5g, 2.38 mM). 1H NMR (CDCl3): delta 7.58-7.60 (M, 2H), 7.26-7.36 (M, 8H), 6.74-6.80 (M,-CONH), 4.32-4.35 (M, 1H), 3.54-3.62 (M, 2H), 2.79-3.00 (M, 3H), 2.47-2.49 (brs, 1H, OH), 2.09-2.28 (M, 2H), 1.54-1.62 (M, 9H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With triphenylphosphine; In tetrahydrofuran; at 20℃; for 20h; | The compound <strong>[427-49-6]2-cyclopentyl-2-hydroxy-2-phenylacetic acid</strong> (0.3 g, 1.36 mM), (3R)-1- benzyl-pyrrolidin-3-ol (0.2 g, 1.14 mM) and triphenylphosphine (0.36 g, 1.36 MM) were dissolved in dry tetrahydrofuran (10.0 ml). To this, a solution of DIETHYLAZABICYCLOCARBOXYLATE (0.2 ml, 1.36 mM) in dry tetrahydrofuran (2.0 ml) was added dropwise under nitrogen atmosphere at room temperature with constant stirring and the stirring was continued for 20 hours. Tetrahydrofuran was evaporated under vacuum and the residue was taken in chloroform and washed with saturated sodium bicarbonate solution, water and brine solution followed by drying and concentrating over anhydrous sodium sulphate. The residue was purified by silica gel column chromatography using 30% ethyl acetate in hexane to get the title compound as oil. Yield = 91% (0.39 g, 1.03 MM). 1H NMR (CDCl3) : delta 7.64-7.67 (M, 2H), 7.26-7.35 (M, 8H), 5.17-5.23 (M, 1H), 3.56-3.74 (M, 3H), 2.75-2.90 (M, 4H), 2.00-2.52 (M, 3H, including-OH), 1.29-2.00 (M, 8H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In DMF (N,N-dimethyl-formamide); at 0 - 20℃; for 60h; | To a solution of 4-(1, 5-dimethyl-3-azabicyclo [3.1. 0] hex-3-yl)-2-butynol [(1] mmol, 0.18 gm) in [DM ! ?] (5 ml) was added 2-hydroxy-2-cyclopentyl-2-phenyl acetic acid (1 mmol, 0. [ 22)] gm) and cooled to [0C.] The reaction mixture was treated with hydroxy benzotriazole (1 mmol, 0.135 g) followed by N-methyl morpholine (2 mmol, 0.202 gm) and stirred at [0C] for 0-5 hours. EDCI (1 mmol, 0.192 gm) was then added and the reaction mixture after being stirred at [0C] for 1 hr. was stirred at room temperature for 2 days. The reaction mixture was poured into water and extracted with ethylacetate. The organic layer was dried over sodium sulphate. The crude compound obtained after evaporation of solvent was purified by column chromatography (silicagel 100-200 mesh), eluting the compound with 20-80 ethyl acetate-hexane mixture. 1H-NMR [(CDC13)] delta-values: 7.67-7. 24 [(M,] arom, [5H),] 4. [86-4.] 66 [(DD"2H),] 3.66 (s, 1H), [3.] 36 (s, 2H), 2.92-2. 83 (m, 3H), 2.36-2. 32 [(M,] 2H), 1.68-0. 92 [(M,] [15H),] 0. [01103 (D, 1H).] IR [(DCM)] : 1731 [CM'] |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 1,8-diazabicyclo[5.4.0]undec-7-ene; In toluene; for 2h;Heating / reflux; | EXAMPLE 3 Preparation of (1 ALPHA;,5 ALPHA;)-[3-BENZYL-3-AZABICYCLO[3.1.0] HEX-1-(METHYL)-YL]-2-HYDROXY-2- CYCLOPENTYL-2-PHENYLCARBOXYLIC ester (Compound No. 3) A solution of 2-cyclopentyl-2-hydroxy-2-phenyl acetic acid (prepared as described in J. Amer. Chem. Soc. , 75,2654, 1953) (375 mg, 0.0017 mole), 3-benzyl-l-methane sulphonyl-3-azabicyclo [3.1. 0] hexane (400 mg, 0.00142 mole) and 1,8- diazabicyclo [5.4. 0] undec-7-ene (323 mg, 0.00213 mole) in toluene (50 ml) was refluxed for 2 hour. The solution was cooled to room temperature and stripped off the solvent to give crude oily product. The crude product was further purified by column chromatography (100-200 mesh, silicagel), eluting the compound with 5% ethyl acetate in hexane to give the desired product. IR: 1720.3 CRRI 1 1HNMR (CDC13) : 7.17-7. 66 (M, 10H), 4.21 (s, 2H), 3.75 (bs, 1H), 3.53 (s, 2H), 2. 86-2. 91 (M, 2H), 2.21-2. 27 (M, 2H), 1.31-1. 38 (M, 8H), 1.12-1. 15 (M, 2H), 0.25 (M, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; N-ethyl-N,N-diisopropylamine; In hydrochloric acid-methanol; N,N-dimethyl-formamide; | Structural formula STR14 Step 1. Synthesis of N-(piperidin-4-yl)-2-cyclopentyl-2-hydroxy-2-phenylacetamide To a solution of 3.51 g of <strong>[427-49-6]2-cyclopentyl-2-hydroxy-2-phenylacetic acid</strong> in 40 ml of N,N-dimethylformamide, 2.63 g of 1,1'-carbonyidiimidazole was added and stirred at room temperature for 2 hours. To the reaction mixture 3.96 g of 4-amino-1-(t-butoxycarbonyl)piperidine monohydrochloride, 200 mg of 4-dimethylaminopyridine and 6.9 ml of diisopropylethylamine were added, followed by stirring overnight at room temperature. Saturated aqueous sodium bicarbonate solution was added to the reaction mixture followed by an extraction with diethyl ether. The organic layer was washed with brine and dried over anhydrous sodium sulfate. Distilling the solvent off under reduced pressure, the resultant residue was purified by silica gel column chromatography (developing solvent: hexane/ethyl acetate=3/1) to provide 2.84 g of a white solid. The solid was dissolved in 30 ml of 10% hydrochloric acid-methanol, and stirred overnight at room temperature. Distilling the methanol off under reduced pressure, the residue was diluted with water and washed with diethyl ether. The aqueous layer was made basic with sodium hydroxide and extracted with chloroform. The organic layer was washed with water and then with brine, and dried over anhydrous magnesium sulfate. Distilling the solvent off under reduced pressure, 2.15 g of the title compound was obtained as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; | (1) Synthesis of N-(1-t-butoxycarbonylpiperidin-4-yl)-2-cyclopentyl-2-hydroxy-2-phenylacetamide STR6 To a solution of 716 mg of <strong>[427-49-6]2-cyclopentyl-2-hydroxy-2-phenylacetic acid</strong> as obtained in Step (1A) of Example 1 in 5 ml of N,N-dimethylformamide, 540 mg of 1,1-carbonyldiimidazole was added at room temperature, and stirred for an hour at the same temperature. Further 846 mg of 4-amino-1-t-butoxycarbonylpiperidine hydrochloride and 1 ml of diisopropylethylamine were added, followed by 16 hours' stirring. The reaction mixture was poured into water and extracted with diethyl ether. The extract was sequentially washed with water and saturated saline solution, dried over anhydrous magnesium sulfate and removed of the solvent by reduced pressure distillation. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=4/1 to 1/1) to give 752 mg of the title compound as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 16 N-[1-(4-Methyl-3-pentenyl)piperidin-4-yl]-2-cyclopentyl-2-hydroxy-2-phenylacetamide The title compound was prepared in the same manner as described in Steps 2 to 4 of Example 1 using <strong>[427-49-6]2-cyclopentyl-2-hydroxy-2-phenylacetic acid</strong>. 1 H-NMR (CDCl3, delta ppm): 1.12-1.28 (1H, m), 1.32-1.90 (11H, m), 1.60 (3H, s), 1.68 (3H, s), 2.03-2.19 (4H, m), 2.26-2.32 (2H, m), 2.72-2.82 (2H, m), 2.95-3.09 (1H, m), 3.14 (1H, s), 3.62-3.77 (1H, m), 5.04-5.10 (1H, m), 6.31 (1H, d, J=7.9 Hz), 7.23-7.38 (3H, m), 7.57-7.61 (2H, m). Low Resolution FAB-MS (m/e, as (C24 H36 N2 O2 +H)+): 385 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With 4-methyl-morpholine; benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; In N,N-dimethyl-formamide; at 0 - 20℃; | To a solution of a compound obtained from step b above (29.9 mmole, 6.05 g) in dimethylformamide (100 ml) was added 2-hydroxy-2-cyclopentyl-2 -phenyl acetic acid (commercially available) (27.2 mmole, 6.0 g) followed by the addition of l-(3- dimethylaminopropyl)-3-ethyl carbodiimide and cooled at 0C. The reaction mixture was treated with hydroxy benzotriazole (29.9 mmole, 4.04 gm) followed by addition of N- methyl morpholine (54.4 mmole, 5.2 g) and was stirred at 00C for lhour and at room temperature overnight. The reaction mixture was poured into saturated sodium bicarbonate solution. The organic compound was extracted with ethyl acetate. The organic layers were washed with water and dried over anhydrous sodium sulphate and EPO <DP n="28"/>concentrated under reduced pressure. The residue was purified by column chromatography to yield the title compound with 95% yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
17% | Example 1: Preparation of (2R, 2S)-rf3'R, 3'SV l^(fR)-a-methvl-benzvri-pvrrolidin-3'-vlmethvl]-2-hvdroxv-2-cvcopentvl-2-phenvlacetic acid ester (Compound No. 1)To a solution of 2-hydroxy-2-cyclopentyl-2-phenyl acetic acid (prepared following the procedure described in J. Amer. Chem. Soc. 75, 2654 (1953); J. Org. Chem. 2000, 65, 6283-6287) (0.59 g, 2.7 mm) and l-((R)-a-methyl benzyl)-3-pyrrolidin methanol (0.5 g, 2.4 mm) (prepared according to the method described in J. Med. Chem., 1987, 30, 1711)in dimethylformamide (10.0 ml) at about 0-5C, hydroxy benzotriazole (0.36 g, 2.7 mm) and N-methylmorpholine (0.54 ml, 4.9 mm) were added and stirred at the same temperature for about 1 hour. l-(3-dimethylaminopropyl)-3-ethyl carbodiimide hydrochloride (0.48 g, 2.4 mm) was added and stirring was continued for about 1 hour at about 0-5C. The reaction mixture was stirred at about 25 to 30 C for about 15 hours. The reaction mixture was poured onto water, extracted with ethyl acetate and ethyl acetate layer was washed with water and brine solution, dried over anhydrous sodium sulphate and concentrated. The residue was purified by silica gel column chromatography using 50% ethyl acetate in hexane to get the title product in 17% (0.17 g) yield.IR(DCM): 1722.9 cm"1'H NMR (CDC13): 5 7.59-7.61 (m, 2H), 7.29-7.39 (m, 8H), 4.06-4.07 (m, 2H), 3.68-3.78(m, 1H), 3.50 (m, 1H), 3.14-3.16 (m, 1H), 2.84 (m, 1H), 2.36-2.56 (m, 4H), 2.10 (s, 1H),1.70-1.80 (m, 1H), 1.50-1.69 (m, 8H), 1.34-1.47 (m, 3H)Mass: 408 (M+l) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
A solution of a compound 2-cyclopentyl-2-hydroxy-phenylacetic acid (synthesis as per procedure reported in/. Am. Chem. Soc, 75:265 (1953) and EP 613232, (1.415 mmol, 1 eq.) and te7t-butyl-3-azabicyclo[3.1.0]hex-6-yl(methyl)carbamate (1.415 mmol) in dimethylformamide (10 mL) was cooled in an ice bath followed by the addition of N- methylmorpholine (0.28 g) and 1-hydroxy benzotriazole (0.21 g). The reaction mixture was stirred for 1 hour in an ice bath, l-(3-dimethylamino propyl)-3 -ethyl carbodiimide hydrochloride (0.27g) was added and the reaction mixture was stirred for 1 hour and subsequently overnight. The reaction mixture was poured in saturated sodium bicarbonate solution and extracted with ethyl acetate. The organic layer was washed with brine, dried over anhydrous sodium sulphate and concentrated under reduced pressure. The residue thus obtained was purified by column chromatography using 20 % ethyl acetate in hexane solvent mixture to yield the title compound. Yield = 280 mg. m.p: 76-79.6 0C. 1H NMR: delta 7.40-7.26 (m, 5H), 3.98-2.66 (m, 7H), 1.65-1.21 (m, 20H). IR: 1623, 1700 cm 1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; sodium hydroxide; phosphorus pentachloride; triethylamine; In chloroform; toluene; | EXAMPLE 60 A mixture of <strong>[427-49-6]2-cyclopentyl-2-hydroxy-2-phenylacetic acid</strong> (2.50 g), phosphorus pentachloride (5.20 g) and toluene (10 ml) was heated at 90 C. for 2 hours. After being cooled, the solution was evaporated under reduced pressure and coevaporated several times with toluene. The residue was dissolved in chloroform (10 ml) and the solution was added dropwise to a solution of 4-dimethylamino-2-butynylamine (1.21 g) and triethylamine (1.6 ml) in chloroform (10 ml) at 0-5 C. After being stirred for 17.5 hours at room temperature, the solution was made alkaline with 1N aqueous solution of sodium hydroxide and extracted with chloroform. The extract was washed with brine, dried over magnesium sulfate, and evaporated in vacuo. To the residue, 1N hydrochloric acid (20 ml) and 1,4-dioxane (40 ml) were added and heated at 90 C. for 40 minutes. After being cooled, the solution was made alkaline with 1N aqueous solution of sodium hydroxide and extracted with ethyl acetate. The extract was washed with brine, dried over magnesium sulfate and condensed under reduced pressure. The residue was purified by column chromatography on silica gel with a mixture of chloroform and methanol as an eluent to give N-(4-dimethylamino-2-butynyl)-2-cyclopentyl-2-hydroxy-2-phenylacetamide (0.98 g). IR (film): 3400, 1650, 1600 cm-1. NMR (CDCl3, delta): 1.04-1.32 (1H, m), 1.39-1.79 (7H, m), 2.23 (6H, s), 2.95-3.25 (2H, m), 3.17 (2H, t, J=1.9Hz), 3.86-4.14 (2H, m), 6.69 (1H, m), 7.20-7.30 (3H, m), 7.54-7.69 (2H, m). Mass: 314, 175. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; for 2h; | To a mixture of racemic cyclopentylmandelic acid R/S(+/-)1 (4.47 g, 20 mmol) and potassium carbonate (7.01 g, 50 mmol) in DMF (50 ml), methyl iodide (8.64 g, 60 mmol) was added at room temperature. The mixture was stirred at room temperature for 2 h, and then poured into water and extracted with hexanes three times. Evaporation of the dried hexanes extract gave a crude product. Flash chromatography of the crude product on silica gel with 1.5:1 hexanes:methylene chloride gave the pure product 2 (3.02 g, 64%). 1H NMR(CDCl3, 300 MHz): 1.32-1.37, 1.43-1.69 [8H, m, (CH2)4], 2.90 [1H, p, CHC(OH)], 3.74(1H, s, OH), 3.77 (3H, s, CH3), 7.25-7.37, 7.63-7.65 (5H, m, Ph) ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83.4% | [0150] In a 5L three-necked flask, 320 g (1.453 mol) of cyclopentylmandelic acid racemate, 2670 mL of acetonitrile and 211 mL of water were added, stirred and heated for dissolution. The temperature of the reaction mixture was 40-45 C, at which time the solid was completely dissolved. 141.53g (0.725 mol) of D-tyrosine methyl ester was added at this temperature to precipitate a solid. A heating was performed until the reaction mixture was refluxed and the solid was completely dissolved so that a clear and transparent solution is obtained. The heating was stopped, the reaction mixture was cooled to 0 C in an ice bath, and the reaction was continued with stirring for 4 hours to precipitate a large amount of crystals. The solid was collected by filtration, washed with acetonitrile three times (3150 mL), and dried to obtain 230.69 g of R-cyclopentylmandelic acid D-tyrosine methyl ester salt with a yield of 76.6%. [0151] 230.69 g of the above R-cyclopentylmandelic acid D-tyrosine methyl ester salt was added to a 5L three-necked flask, and 2000 mL of toluene and 1000 mL of water were added. 66 mL of concentrated hydrochloric acid was added with stirring, heated to 40 C in an water bath until the solid was completely dissolved, and cooled. The aqueous phase and organic phase were separated with a separatory funnel. 20 mL of concentrated hydrochloric acid was added to the aqueous phase and extracted twice (2250 mL) with toluene. The organic phases were combined and dried over anhydrous magnesium sulfate. The desiccant was removed by filtration, the solvent was removed under reduced pressure, and the residue was added with 500 mL of n-hexane and stirred to produce a large amount of solid. The solid was filtered and dried at 45 C for 3 hours to obtain 134.4 g of R-cyclopentylmandelic acid white solid with a yield of 83.4%. | |
33.3 - 37.6% | (-)-Strychnine (6.10 g) in 50 ml of methanol (suspension) was added to racemic cyclopentylmandelic acid 1, (3.96 g) in methanol (20 ml) at room temperature. The reaction solution was let to stand for overnight. The crystals were removed by filtration and crystallized again with hot methanol. The second crop of crystals was collected by filtration and treated with sodium hydroxide solution. The basic solution was extracted with methylene chloride twice (methylene chloride solution discarded), and then acidified with hydrochloric acid to recover the resolved cyclopentylmandelic acid. To this resolved acid (20.6 mg in 0.1 ml of ethyl acetate), 13 muL of (+)-alpha-phenylethylamine was added. The precipitate which formed was washed with hexane three times and dried under vacuum. The precipitate was identified by NMR as optically pure cyclopentylmandelic acid, R(-)1, (1.49 g, 37.6%). M.p.: 121-122 C. [alpha]25D=-22.5 (c=1 g/100 ml, CHCl3). 1H NMR(CDCl3, 500 MHz): 1.28-1.39, 1.42-1.50, 1.51-1.61, 1.64-1.73 [8H, m, (CH2)4], 2.93 [1H, p, CHC(OH)], 7.25-7.28, 7.32-7.35, 7.64-7.65(5H, m, Ph) ppm. ; (-)-Strychnine (11.4 g) in 100 ml of methanol (suspension) was added to racemic cyclopentylmandelic acid 1 (7.5 g) in methanol (20 ml) at room temperature. The reaction solution was allowed to stand overnight. The crystals were filtered and crystallized again with hot methanol. The second crop of crystals was collected by filtration and treated with sodium hydroxide solution. The basic solution was extracted with methylene chloride twice (methylene chloride solution discarded), and then acidified with hydrochloric acid to recover the resolved cyclopentylmandelic acid. To this resolved acid (20.6 mg in 0.1 ml of ethyl acetate), 13 muL of (+)-alpha-phenylethylamine was added. The precipitate which formed was washed with hexane three times and dried under vacuum. The precipitate was identified by NMR as optically pure cyclopentylmandelic acid, R(-)1, (2.5 g, 33.3%). M.p.: 121-122 C. [alpha]25D=-22.5 (c=1 g/100 ml, CHCl3). 1H NMR(CDCl3, 300 MHz): 1.28-1.39, 1.42-1.50, 1.51-1.61, 1.64-1.73 [8H, m, (CH2)4], 2.93 [1H, p, CHC(OH)], 7.25-7.28, 7.32-7.35, 7.64-7.65(5H, m, Ph) ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 1,8-diazabicyclo[5.4.0]undec-7-ene; In toluene;Heating / reflux; | Example 3: Synthesis of 2-(2 -methyl- lH-imidazol-l-yl)ethyl cyclopentyl(hydroxy) phenylacetate (Compound No. 13) To a solution of the compound 2-cyclopentyl-2-hydoxy-2 -phenyl acetic acid (388 mg,1.7mmol), methanesulphonic acid 2-(2-methyl-imidazol-l-yl)-ethyl ester (300 mg, 1.4mmol) <n="44"/>and toluene (15 ml) was added l,8-diazabicyclo[5.4.0]undecen-7-ene (447 mg, 2.9mmol) and stirred the mixture overnight under reflux. The organic solvent was evaporated under reduced pressure and the residue thus obtained was purified by column chromatography using 5% methanol in dichloromethane. Yield: 60mg. 1H NMR (CDCl3)delta: 7.52-7.54 (m, 2H), 7.28-7.35 (m, 3H), 6.90 (s, IH), 6.71 (s, IH), 4.36- 4.39 (m, 2H), 4.06-4.09 (m, 2H), 2.81-2.85 (q, IH), 2.31 (s, 3H), 1.33-1.57 (m, 8H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With 4-methyl-morpholine; benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; In N,N-dimethyl-formamide; at 0 - 20℃; | Step c: Synthesis of (1alpha,5alpha,6alpha)-N-(3-benzyl-3-azabicyclo[3.1.0]hex-6-ylmethyl)-2-cyclopentyl-2-hydroxy-2-phenyl Acetamide To a solution of a compound obtained from step b above (29.9 mmole, 6.05 g) in dimethylformamide (100 ml) was added 2-hydroxy-2-cyclopentyl-2-phenyl acetic acid (commercially available) (27.2 mmole, 6.0 g) followed by the addition of 1-(3-dimethylaminopropyl)-3-ethyl carbodiimide and cooled at 0 C. The reaction mixture was treated with hydroxy benzotriazole (29.9 mmole, 4.04 gm) followed by addition of N-methyl morpholine (54.4 mmole, 5.2 g) and was stirred at 0 C. for 1 hour and at room temperature overnight. The reaction mixture was poured into saturated sodium bicarbonate solution. The organic compound was extracted with ethyl acetate. The organic layers were washed with water and dried over anhydrous sodium sulphate and concentrated under reduced pressure. The residue was purified by column chromatography to yield the title compound with 95% yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75.34% | Example 8: Synthesis of N-(l-benzyl-pvrrolidin-3-vlmethvf)-2-cvclopentvl-2-hvdroxv-N-methyl-2-phenyl-acetamide (Compound No. 25)To a solution of the compound 2-cyclopentyl-2-hydroxy-2-phenyl acetic acid (leq.) in dimethylformamide was added hydroxybenzotriazole (1.5eq.), l-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (leq.) and dimethylaminopyridine (catalytic amount). The reaction mixture was stirred at 15-20C for 2 hours followed by the addition of N-methylmorpholine (2 eq.) and a solution of the compound (l-benzyl-pyrrolidin-3-ylmethyl)-methyl-amine (1 eq.) in dimethylformamide (10 ml). The resulting reaction mixture was stirrei 15-20C for 1 hour and subsequently at room temperature for 14 hours. To the mixture was ad water and stirred for 15 minutes. The aqueous layer was extracted with ethylacetate. The orgar layer was washed with sodium bicarbonate solution, water and brine, dried over anhydrous sodium sulphate and concentrated under reduced pressure. The residue thus obtained was purii by column chromatography to furnish the title compound. Yield: 75.34%.Mass(nVz): 407.0 (M++l).IR: 1623.8 cm-1, 2951.2 cm-1, 3357.5 cm-1.'HNMR: 1.256-1.663 (m, 10H), 2.014-2.559 (m, 6H), 2.713-2.951 (m, 4H), 3.399-3.461 (m, 2H), 3.801 (s, 2H), 7.105-7.334 (m, 10H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In acetonitrile; at 0 - 20℃; for 2h; | Example 3; Preparation of l-cyclopentyl^-hydroxy-l-imidazol-l-yl^-phenyl-ethanone, the active intermediate; The imidazolidyl derivative of cyclopentylmandelic acid was prepared and isolated as a solid by the following method:10 g of cyclopentylmandelic acid were suspended in 30 ml of acetonitrile and the mixture was cooled to 00C. 10.3 g of carbonyldiimidazole were added as a solid and the mixture was warmed to room temperature for 2 hours. Carbon dioxide evolved as a gas as a precipitate formed. The mixture was then cooled to 50C and the solid was filtered, washed with acetonitrile and dried in vacuum at 400C to obtain 7.3 g of pure 2-cyclopentyl-2-hydroxy-l- imidazol-l-yl-2-phenyl-ethanone.; This process is summarised in the following reaction scheme:High resolution MS-spectroscopy revealed the molecular formula of the compound (as M+H) to be C16H19O2N2 with an exact mass of 271.14414 (0.14575ppm deviation from the calculated value).Eta-NMR-spectroscopy (600MHz, DMSO-d6): 1.03-1.07 (m, IH), 1.25-1.30 (m, IH), 1.35- 1.40 (m, IH), 1.40-1.50 (m, IH), 1.53-1.56 (m, 2H), 1-60-1.67 (m, IH), 1.75-1.84 (m, IH), 1.03 - 1.85 (8H, 8 secondary CH2-protons in the cyclopentylring, H-CIl, H-C12, H-C13, H-C14); 2.7-2.9 (m, IH, H-ClO); 6.76 (IH, H-C5); 6.91 (IH, H-C4); 7.29 (IH, H-C18); 7.39 (2H, H-C17, H-C19); 7.49 (2H, H-C16, H-C20); 7.65 (IH, H-C2). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 1; Preparation of (3S,2'R)- and (3R,2'S)-3-[(cyclopentyl-hydroxyphenylacetyl)-oxy]-l,l- dimethylpyrrolidinium bromide; 30 g of cyclopentyl mandelic acid, dissolved in 135 g dimethylformamide (DMF), were treated with 27 g carbonyldiimidazole at 180C (in portions) to form the "active amide". After the addition of 16.9 g of l-methyl-pyrrolidin-3-ol, the mixture was heated to 600C within 1 hour and stirred for 18 hours at this temperature. After checking for complete conversion, the mixture was cooled and 200 g water was added. The mixture was extracted with 200 g toluene and the extract was washed with water three times. The organic phase was concentrated to obtain cyclopentyl-hydroxy-phenyl-acetic acid l-methyl-pyrrolidin-3-yl ester as an about 50percent solution in toluene, ready to use for the next step.This solution was diluted with 120 g of n-propanol and cooled to O0C. 16.8 g methyl bromide was introduced and the mixture was stirred for 2 hours and then gradually heated to 60°C to evaporate the excess methyl bromide into a scrubber. The mixture was then cooled to 500C and seed crystals were added to facilitate crystallisation. The temperature was then slowly reduced over 18 hours to 15°C. The solid was then isolated by filtration to obtain 22.7 g after drying. It was composed mainly of one pair of enantiomers, a racemic mixture of (3S,2'R)- and (3R,2'S)-3-[(cyclopentyl-hydroxyphenylacetyl)-oxy]-l,l- dimethylpyrrolidinium bromide, with a purity greater than 90percent (by HPLC). The other pair of diastereoisomers ((3R,2'R)- and (3S,2'S)-3-[(cyclopentyl-hydroxyphenyl-acetyl)-oxy]-l,l- dimethylpyrrolidinium bromide) remains mainly in the filtrate as those compounds are significantly more soluble in n-propanol than the other stereoisomers.The solid obtained is further recrystallised in n-propanol (1:10 wt) to give pure (3S,2'R)- and (3R,2'S)-3-[(cyclopentyl-hydroxyphenylacetyl)-oxy]-l,l-dimethylpyrrolidinium bromide i.e. purity >; 99.9percent as determined by high performance liquid chromatography (HPLC). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 1 : Synthesis of 2-Cyclopentyl-2-hydroxy-lambda/-[2-(lH-imidazol-l-yl)ethyll-2- phenylacetamide (Compound No. 1) <n="36"/>To a solution of the hydrochloride salt of 2-(lH-imidazol-l-yl)ethanamine (0.5 g, 4.50 mmol) in chloroform (10 ml) was added N-methyl morpholine (2.96 ml, 27.02 mmol) and stirred the mixture for 5 to 10 minutes at the room temperature followed by the addition of 2- cyclopentyl-2-hydroxy-2-phenyl acetic acid (0.99 g, 4.5 mmol) and hydroxy benzotriazole (0.60 g, 4.5 mmol) at room temperature. The resulting reaction mixture was stirred for 30-45 minutes followed by the addition of l-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and again stirred for over night. The mixture was diluted with water and stirred for 10-15 minutes followed by the addition of dichloromethane. The mixture was stirred for 15-20 minutes. The organic layer was separated, washed with water and brine, dried over anhydrous sodium sulphate and concentrated under reduced pressure. The residue thus obtained was purified by preparative column chromatography using 10 % methanol in dichloromethane as eluent to furnish the title compound. Yield: 70 mg.1H NMR (CDCl3)delta: 7.60-7.31 (5H, m), 6.99 (IH, s), 6.99 (IH, s), 6.65 (IH, s), 4.01-4.00 (2H, m), 3.99-3.49 (2H, m), 3.11-3.07 (IH, m), 1.64-1.42 (8H, m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 2: Synthesis of lH-imidazol-1-ylmethyl cyclopentyl(hydroxy)phenylacetate (Compound No. 46)To a solution of 2-cyclopentyl-2-hydoxy-2 -phenyl acetic acid (400 mg, 1.8 mmol) in dry tetrahydrofuran (20 ml) under argon atmosphere was added carbonyldiimidazole (294 mg, 1.8 mmol) and stirred the mixture for 5 min. To the resulting reaction mixture was added <n="43"/>imidazol-lyl-methanol (178 mg, 1.8 mmol) and stirred for 24 hours. The mixture was concentrated under reduced pressure and the residue thus obtained was washed with water and extracted with dichloromethane. The organic layer was washed with water and brine, dried over anhydrous sodium sulphate and concentrated under reduced pressure. The residue thus obtained was purified by column chromatography using 5 % methanol in dichloromethane to furnish the title compound. Yield: 140mg.1H NMR (CD3OD)delta: 7.68 (s, IH), 7.55-7.57 (m, 2H), 7.28-7.34 (m, 3H), 7.04-7.11 (m, 2H), 5.76-6.06 (m, 2H), 2.77-2.86 (m, IH), 1.27-1.62 (m, 8H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 16h; | General procedure: t-Butyloxycarbonylpiperazine (1.0 equivalent) was added to solutions of carboxylic acids (1 .0 equivalents), HOBt (1.25 equivalents) and EDCI (1 .05 equivalents) in DMF (0.7M solution), followed by DIPEA (1.0 equivalents) and the mixture stirred at RT for 16h. The reactions were monitored by TLC using either MeOHiCHC or EA:HEX mixtures and PMA staining until substantial amount of product was observed. The reaction mixtures were diluted with MTBE (5vol) and sequentially washed with 0.1 N HCI (1vol), sat'd NaHCC>3 (1vol), dried with Na2S04, filtered and the solvents removed in vacuo. The crude product H-S1-P was pure enough to be used without purification for the next step. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 16h; | General procedure: General Procedure I: Amines (1.0 equivalents) were added to solutions of carboxylic acid (1.0 equivalents), hydroxybenzotriazole (HOBt) (1.25 equivalents) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) (EDCI) (1 .05 equivalents) in dimethylformamide (DMF) (0.7M solution), followed by diispropylethylamine (DIPEA) (1.0 equivalents) and the mixture stirred at RT for 16h. The reactions were monitored by TLC using methanol:chloroform (MeOH:CHCI3) mixtures and PMA staining until substantial amount of product was observed. The solutions were partitioned between 15% isopropyl alcohol(IPA) in CHCI3: iN NaOH (Svol:Svol) and the organic layer dried with sodium sulfate (Na2504), filtered and the solvents removed in vacuo. The crude products were purified by FC on silica gel using suitable solvent mixtures of MeOH:CHCI3 depending on TLC conditions. Product purity was determined by HPLC and product identity confirmed by LC-MS (ESl+) and 1H NMR. |
Tags: 427-49-6 synthesis path| 427-49-6 SDS| 427-49-6 COA| 427-49-6 purity| 427-49-6 application| 427-49-6 NMR| 427-49-6 COA| 427-49-6 structure
[ 4335-77-7 ]
2-Cyclohexyl-2-hydroxy-2-phenylacetic acid
Similarity: 0.96
[ 19833-96-6 ]
Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate
Similarity: 0.88
[ 611-71-2 ]
(R)-2-Hydroxy-2-phenylacetic acid
Similarity: 0.87
[ 63628-25-1 ]
2-Methoxy-2-(naphthalen-1-yl)propanoic acid
Similarity: 0.80
[ 4335-77-7 ]
2-Cyclohexyl-2-hydroxy-2-phenylacetic acid
Similarity: 0.96
[ 19833-96-6 ]
Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate
Similarity: 0.88
[ 611-71-2 ]
(R)-2-Hydroxy-2-phenylacetic acid
Similarity: 0.87
[ 7326-19-4 ]
(R)-2-Hydroxy-3-phenylpropanoic acid
Similarity: 0.78
[ 4335-77-7 ]
2-Cyclohexyl-2-hydroxy-2-phenylacetic acid
Similarity: 0.96
[ 611-71-2 ]
(R)-2-Hydroxy-2-phenylacetic acid
Similarity: 0.87
[ 63628-25-1 ]
2-Methoxy-2-(naphthalen-1-yl)propanoic acid
Similarity: 0.80
[ 7326-19-4 ]
(R)-2-Hydroxy-3-phenylpropanoic acid
Similarity: 0.78
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :